back
SEDI Insider filing browser
| Date | Issuer | Insider | Transaction | Amount | New Balance ⓘ
The balance of securities held by registered holder at the time of the transaction. Insiders may direct multiple registered holders and hold multiple security types.
|
|
|---|---|---|---|---|---|---|
| Filed 2024-03-05 12:42 Tx date 2024-01-21 |
$INM
InMed Pharmaceuticals Inc. |
Mancini, Alexandra Diane Janet
5 - Senior Officer of Issuer
Direct Ownership
|
Options
52 - Expiration of options
|
$-50,910.75
-121 vol $420.75 each |
52,485 | |
| Filed 2023-12-26 11:04 Tx date 2023-12-23 |
$INM
InMed Pharmaceuticals Inc. |
Mancini, Alexandra Diane Janet
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$16,650
+45,000 vol $0.37 each |
52,606 | |
| Filed 2023-05-16 12:10 Tx date 2023-05-16 |
$INM
InMed Pharmaceuticals Inc. |
Mancini, Alexandra Diane Janet
5 - Senior Officer of Issuer
Direct Ownership
|
Options
52 - Expiration of options
|
$-408,127.50
-485 vol $841.50 each |
7,606 | |
| Filed 2023-03-08 13:02 Tx date 2023-03-08 |
$INM
InMed Pharmaceuticals Inc. |
Mancini, Alexandra Diane Janet
5 - Senior Officer of Issuer
Direct Ownership
|
Options
52 - Expiration of options
|
$-78,003.75
-61 vol $1,278 each |
8,091 | |
| Filed 2022-12-19 15:05 Tx date 2022-12-16 |
$INM
InMed Pharmaceuticals Inc. |
Mancini, Alexandra Diane Janet
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$7,476
+4,200 vol $1.78 each |
8,152 | |
| Filed 2022-11-17 15:14 Tx date 2022-11-14 |
$INM
InMed Pharmaceuticals Inc. |
Mancini, Alexandra Diane Janet
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$11,676
+4,200 vol $2.78 each |
||
| Filed 2022-11-15 18:06 Tx date 2022-11-14 |
$INM
InMed Pharmaceuticals Inc. |
Mancini, Alexandra Diane Janet
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$11,676
+4,200 vol $2.78 each |
||
| Filed 2022-11-15 18:06 Tx date 2022-11-14 |
$INM
InMed Pharmaceuticals Inc. |
Mancini, Alexandra Diane Janet
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$11,676
+4,200 vol $2.78 each |
8,152 | |
| Filed 2022-10-25 17:16 Tx date 2022-09-07 |
$INM
InMed Pharmaceuticals Inc. |
Mancini, Alexandra Diane Janet
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
37 - Stock split or consolidation
|
-5,819 vol |
240 | |
| Filed 2022-10-12 18:17 Tx date 2022-09-07 |
$INM
InMed Pharmaceuticals Inc. |
Mancini, Alexandra Diane Janet
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
37 - Stock split or consolidation
|
-5,817 vol |
||
| Filed 2022-10-12 18:17 Tx date 2022-09-07 |
$INM
InMed Pharmaceuticals Inc. |
Mancini, Alexandra Diane Janet
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
37 - Stock split or consolidation
|
-5,817 vol |
242 | |
| Filed 2022-10-12 18:16 Tx date 2022-09-07 |
$INM
InMed Pharmaceuticals Inc. |
Mancini, Alexandra Diane Janet
5 - Senior Officer of Issuer
Direct Ownership
|
Options
37 - Stock split or consolidation
|
-94,835 vol |
3,952 | |
| Filed 2022-06-02 11:38 Tx date 2022-06-02 |
$INM
InMed Pharmaceuticals Inc. |
Mancini, Alexandra Diane Janet
5 - Senior Officer of Issuer
Direct Ownership
|
Options
52 - Expiration of options
|
$-22,497.75
-1,515 vol $14.85 each |
98,787 | |
| Filed 2022-02-23 15:42 Tx date 2022-02-23 |
$INM
InMed Pharmaceuticals Inc. |
Mancini, Alexandra Diane Janet
5 - Senior Officer of Issuer
Direct Ownership
|
Options
52 - Expiration of options
|
$-36,996.30
-3,030 vol $12.21 each |
100,302 | |
| Filed 2022-01-24 16:15 Tx date 2022-01-24 |
$INM
InMed Pharmaceuticals Inc. |
Mancini, Alexandra Diane Janet
5 - Senior Officer of Issuer
Direct Ownership
|
Options
52 - Expiration of options
|
$-78,059.24
-12,121 vol $6.44 each |
103,332 | |
| Filed 2021-10-20 13:56 Tx date 2021-10-18 |
$INM
InMed Pharmaceuticals Inc. |
Mancini, Alexandra Diane Janet
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$49,000
+35,000 vol $1.40 each |
115,453 | |
| Filed 2020-12-19 23:40 Tx date 2020-12-16 |
$IN
InMed Pharmaceuticals Inc. |
Mancini, Alexandra Diane Janet
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$134,750
+35,000 vol $3.85 each |
80,453 | |
| Filed 2020-12-19 23:32 Tx date 2020-06-30 |
$IN
InMed Pharmaceuticals Inc. |
Mancini, Alexandra Diane Janet
5 - Senior Officer of Issuer
Direct Ownership
|
Options
37 - Stock split or consolidation
|
-1,454,547 vol |
45,453 | |
| Filed 2020-12-19 22:43 Tx date 2020-06-30 |
$IN
InMed Pharmaceuticals Inc. |
Mancini, Alexandra Diane Janet
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
37 - Stock split or consolidation
|
-193,941 vol |
6,059 | |
| Filed 2019-11-02 00:41 Tx date 2019-11-01 |
$IN
InMed Pharmaceuticals Inc. |
Mancini, Alexandra Diane Janet
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$8,227
+33,500 vol $0.2456 each |
200,000 | |
| Filed 2019-11-01 10:47 Tx date 2019-10-31 |
$IN
InMed Pharmaceuticals Inc. |
Mancini, Alexandra Diane Janet
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$2,097
+8,500 vol $0.2468 each |
166,500 | |
| Filed 2019-10-29 11:18 Tx date 2019-10-28 |
$IN
InMed Pharmaceuticals Inc. |
Mancini, Alexandra Diane Janet
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$2,600
+10,000 vol $0.26 each |
158,000 | |
| Filed 2019-10-24 19:17 Tx date 2019-10-24 |
$IN
InMed Pharmaceuticals Inc. |
Mancini, Alexandra Diane Janet
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$390.00
+1,500 vol $0.26 each |
148,000 | |
| Filed 2019-10-24 00:10 Tx date 2019-10-22 |
$IN
InMed Pharmaceuticals Inc. |
Mancini, Alexandra Diane Janet
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$2,650
+10,000 vol $0.265 each |
146,500 | |
| Filed 2019-10-24 00:09 Tx date 2019-10-21 |
$IN
InMed Pharmaceuticals Inc. |
Mancini, Alexandra Diane Janet
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$675.00
+2,500 vol $0.27 each |
136,500 | |
| Filed 2019-10-18 22:59 Tx date 2019-10-17 |
$IN
InMed Pharmaceuticals Inc. |
Mancini, Alexandra Diane Janet
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$3,710
+14,000 vol $0.265 each |
134,000 | |
| Filed 2019-10-16 18:27 Tx date 2019-10-16 |
$IN
InMed Pharmaceuticals Inc. |
Mancini, Alexandra Diane Janet
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$2,600
+10,000 vol $0.26 each |
120,000 | |
| Filed 2019-10-15 22:22 Tx date 2019-10-15 |
$IN
InMed Pharmaceuticals Inc. |
Mancini, Alexandra Diane Janet
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$2,800
+10,000 vol $0.28 each |
110,000 | |
| Filed 2019-10-13 16:36 Tx date 2019-10-11 |
$IN
InMed Pharmaceuticals Inc. |
Mancini, Alexandra Diane Janet
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$3,825
+15,000 vol $0.255 each |
100,000 | |
| Filed 2019-10-10 15:35 Tx date 2019-10-10 |
$IN
InMed Pharmaceuticals Inc. |
Mancini, Alexandra Diane Janet
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$3,900
+15,000 vol $0.26 each |
85,000 | |
| Filed 2019-10-09 16:47 Tx date 2019-10-09 |
$IN
InMed Pharmaceuticals Inc. |
Mancini, Alexandra Diane Janet
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$9,446
+35,000 vol $0.2699 each |
70,000 | |
| Filed 2019-10-09 16:46 Tx date 2019-10-07 |
$IN
InMed Pharmaceuticals Inc. |
Mancini, Alexandra Diane Janet
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$9,950
+35,000 vol $0.2843 each |
35,000 | |
| Filed 2019-10-09 16:41 Tx date 2019-10-09 |
$IN
InMed Pharmaceuticals Inc. |
Mancini, Alexandra Diane Janet
5 - Senior Officer of Issuer
Direct Ownership
|
Warrants
55 - Expiration of warrants
|
$-32,500
-50,000 vol $0.65 each |
0 | |
| Filed 2019-05-28 18:32 Tx date 2019-05-27 |
$IN
InMed Pharmaceuticals Inc. |
Mancini, Alexandra Diane Janet
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$174,000
+400,000 vol $0.435 each |
1,500,000 | |
| Filed 2019-01-24 Tx date 2019-01-21 |
$IN
InMed Pharmaceuticals Inc. |
Mancini, Alexandra Diane Janet
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$51,000
+100,000 vol $0.51 each |
1,100,000 | |
| Filed 2018-05-18 Tx date 2018-05-16 |
$IN
InMed Pharmaceuticals Inc. |
Mancini, Alexandra Diane Janet
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$408,000
+400,000 vol $1.02 each |
1,000,000 | |
| Filed 2018-03-11 Tx date 2018-03-08 |
$IN
InMed Pharmaceuticals Inc. |
Mancini, Alexandra Diane Janet
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$77,500
+50,000 vol $1.55 each |
600,000 | |
| Filed 2018-01-17 Tx date 2018-01-15 |
$IN
InMed Pharmaceuticals Inc. |
Mancini, Alexandra Diane Janet
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-1,490
-1,000 vol $1.49 each |
4,700 | |
| Filed 2018-01-17 Tx date 2018-01-16 |
$IN
InMed Pharmaceuticals Inc. |
Mancini, Alexandra Diane Janet
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-7,653.95
-4,700 vol $1.63 each |
0 | |
| Filed 2018-01-13 Tx date 2018-01-12 |
$IN
InMed Pharmaceuticals Inc. |
Mancini, Alexandra Diane Janet
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-11,682.90
-9,000 vol $1.30 each |
5,700 | |
| Filed 2018-01-12 Tx date 2018-01-11 |
$IN
InMed Pharmaceuticals Inc. |
Mancini, Alexandra Diane Janet
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-12,961.88
-9,200 vol $1.41 each |
14,700 | |
| Filed 2018-01-11 Tx date 2018-01-10 |
$IN
InMed Pharmaceuticals Inc. |
Mancini, Alexandra Diane Janet
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-22,100
-13,000 vol $1.70 each |
23,900 | |
| Filed 2018-01-10 Tx date 2018-01-09 |
$IN
InMed Pharmaceuticals Inc. |
Mancini, Alexandra Diane Janet
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-44,747.01
-23,100 vol $1.94 each |
36,900 | |
| Filed 2018-01-09 Tx date 2018-01-08 |
$IN
InMed Pharmaceuticals Inc. |
Mancini, Alexandra Diane Janet
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-86,400
-40,000 vol $2.16 each |
||
| Filed 2018-01-09 Tx date 2018-01-08 |
$IN
InMed Pharmaceuticals Inc. |
Mancini, Alexandra Diane Janet
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-86,492
-40,000 vol $2.16 each |
60,000 | |
| Filed 2017-06-06 Tx date 2017-06-02 |
$IN
InMed Pharmaceuticals Inc. (formerly Cannabis Technologies Inc,) |
Mancini, Alexandra Diane Janet
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$22,500
+50,000 vol $0.45 each |
550,000 | |
| Filed 2017-05-31 Tx date 2016-10-28 |
$IN
InMed Pharmaceuticals Inc. (formerly Cannabis Technologies Inc,) |
Mancini, Alexandra Diane Janet
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2017-05-31 Tx date 2017-05-31 |
$IN
InMed Pharmaceuticals Inc. (formerly Cannabis Technologies Inc,) |
Mancini, Alexandra Diane Janet
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$45,000
+100,000 vol $0.45 each |
100,000 | |
| Filed 2017-05-31 Tx date 2016-10-28 |
$IN
InMed Pharmaceuticals Inc. (formerly Cannabis Technologies Inc,) |
Mancini, Alexandra Diane Janet
5 - Senior Officer of Issuer
Direct Ownership
|
Warrants
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2017-05-31 Tx date 2017-05-31 |
$IN
InMed Pharmaceuticals Inc. (formerly Cannabis Technologies Inc,) |
Mancini, Alexandra Diane Janet
5 - Senior Officer of Issuer
Direct Ownership
|
Warrants
10 - Acquisition or disposition in the public market
|
$32,500
+50,000 vol $0.65 each |
50,000 | |
| Filed 2017-03-10 Tx date 2017-02-20 |
$IN
InMed Pharmaceuticals Inc. (formerly Cannabis Technologies Inc,) |
Mancini, Alexandra Diane Janet
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$37,000
+100,000 vol $0.37 each |
500,000 | |
| Filed 2016-11-04 Tx date 2016-10-28 |
$IN
InMed Pharmaceuticals Inc. (formerly Cannabis Technologies Inc,) |
Mancini, Alexandra Diane Janet
5 - Senior Officer of Issuer
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|
400,000 |